Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE

GSK Poster Hub

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis - Fokkens - 2023 - Allergy - Wiley Online Library

Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trial - eClinicalMedicine

Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study - Aikaterini Detoraki, Eugenio Tremante, Maria D'Amato, Cecilia Calabrese, Claudia

Study Designs NUCALA (mepolizumab) for HCPs

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Respiratory Medicine

Study Designs NUCALA (mepolizumab) for HCPs

Eosinophils & MOA NUCALA (mepolizumab) for CRSwNP

Mepolizumab reduces risk for repeat surgery for chronic rhinosinusitis with nasal polyps

Chronic Rhinosinusitis With Nasal Polyps: Quality of Life in the Biologics Era - ScienceDirect

KoreaMed Synapse

PDF) Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study